В обзоре литературы отражены современные представления о механизмах хронической боли. Детально рассмотрены экспериментальные и клинические исследования, посвященные механизмам хронической боли при остеоартрозе (ОА), в которых показано, что наряду с ноцицептивными механизмами, обусловленными хроническим воспалением и дегенеративными изменениями в области сустава, важную роль в хронизации болевого синдрома может играть и дисфункция самих болевых систем (так называемая дисфункциональная боль). Выделение дисфункциональных механизмов хронической боли при ОА позволяет понять имеющиеся диссоциации между интенсивностью боли и степенью структурных изменений в суставе. Также в статье осуществляются попытки выявить коморбидные заболевания, которые могут дополнительно участвовать в развитии боли. Намечаются эффективные пути лечения ОА. Ключевые слова: остеоартроз; хроническая боль; дисфункциональная боль; коморбидные заболевания.
BackgroundTraditionally, chronic pain in OA is considered to be a classical model of nociceptive pain. Nociceptive mechanism can’t explain the presence: referred pain, secondary hyperalgesia and other sensitive phenomena[.1 Recent studies has shown that besides nociceptive pain there is another mechanism that takes place in chronic pain OA –central sensitisation[.2 Expolore of chronic pain OA can be reached only by a complex approach in examining patients with chronic knee OA that includes not only a rheumatological examination, but examination of the neurological sphere and algometria. At the moment there are only few studies dedicated to neurophysiological changes in pain OA[3 Objectivesto assess pain system with neurophysiological examination in chronic pain OAMethods46 chronic knee pain OA and 23 healthy group control women, 45–65 years old, were included. The study included clinical rheumatologic, neurological examinations, neuropathic pain scales (DN4 and Pain DETECT). Knee X-ray and ultrasound studies. Neurophysiological examination included algometria with algometer and wind-up fenomena observed by Neuropen. Five test sites in the peripatellar region and one control site on tibialis anterior (5 cm distal to the tibial tuberosity) were located and marked for examinationResultsNeuropathic pain scales demonstrated neuropathic descriptors present in OA patients. Neurological examination revealed no somatosensory deficit. But examination of the sensitive sphere indicated hyperalgesia: primary hyperalgesia (increased sensitivity to pain in the damaged joint) and secondary hyperalgesia. Algometria revealed low pressure pain threshold(PPT) above injured knee and intact region compared with healthy group. (tab.1) PPT in intact region was compared between OA patients and control group by ROC-analysis. Max of PPT in intact region in patient with OA was −14,70, min – 1,80, mean value – 7,34. Mean value of PPT in contral group was 15,18. Area under curve was- 0888. Sensitivity – 70%. Specificity – 83%. ROC-analysis demonstrasted that low PPT in OA patints is a specific feature of central sensitisation (figure 1) Wind-up fenomena examination in intact region revealed significant difference of data in OA patients with reffered pain and control group (4,3±2,1 vs 2,44±1,3 p=0,003)and OA patients without reffered pain and control group (3,67±1,43 vs 2,44±1,3 p=0,011).PPT dataOA patients n=46Control group n=23P V17,04±2,9215,13±5,080000V28,41±4,3914,86±4,50001V37,75±3,4516,08±4,970000V44,57±2,211,27±4,980000V54,41±2,110,7±4,80000V67,34±3,6615,18±5,070000Figure 1 Diagonal segments are produced by ties.ConclusionsChronic OA is a complex of mechanisms and includes nociceptive and central sensitisation. Neurophysiological changes: low ppt in demaged area and even intact region and wind-up fenomena were revealed in all OA patients and charectrerises central sensitisation. Mechanism-oriented treatment should also target CNS, including anticonvulsant, and antidepressant agents.References[1] Schaible HG, Ebersberger A, von Banchet G...
BackgroundNSAIDs are widely used for therapy nociceptive pain in osteoarthritis (OA) patients. But in 27% - 61% case this treatment fails to reduce mean pain levels beyond minimal clinically important thresholds [1]. Recent studies have demonstrated that chronic knee OA mechanisms besides nociceptive pain also include central sensitization (CS) (neuroplastic changes in the posterior horn) [2]. CS characterized with neuropathic (NP) phenomena spontaneous and evoked (34% cases), referred hyperalgesia and neurophysiological changes (low pressure pain threshold).Objectivesto evaluate the efficacy of NSAID in patients with “clinical” CS.Methods40 women (age 55±75), II-III grade by Kellgren-Lawrence with chronic knee OA were included. Patients were divided in groups in accordance with the results of neuropathic test DN4 (screening test for CS): patients with positive DN4 (n=11) and patients with negative DN4 (n=29) and accordance with presence of spontaneous NP phenomena (for ex. burning, tingling, current rush): patients with spontaneous NP phenomena (n=29) and patients without spontaneous NP phenomena. Dynamic of OA severity by WOMAC (mm) and pain intensity by VAS (mm) were assessed between groups.ResultsThere was no difference between sociodemographic factors in groups. Statistically and clinically significant reduction in pain score after one-month treatment (n=20) in patients with negative DN4 score was seen (mean pain relief 26mm vs 17 mm, p<0,05). Significant decrease of WOMAC from baseline to final evaluation in patients without spontaneous NP phenomena (mean WOMAC redaction 315 mm vs 199 mm, p<0,05) was demonstrated.ConclusionsPatients with clinical signs of CS have suboptimal pain control. Targeting treatment including anticonvulsants or antidepressants to symptoms of CS in people with OA could lead to benefit.ReferencesBreivik H, Collet B, Ventafridda V, et all, Eur J Pain. 2005; Epub ahead of print.Dieppe PA, Ayis S, Clarke S, Simmons D, Williams S, Fallon 1022 Hochman et al M, et al. Quantitative sensory testing in osteoarthritis of the knee [abstract]. Osteoarthritis Cartilage 2008;16:S204Disclosure of InterestNone declared
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.